Ninlaro

Asia

Legend IPO, China reliance, Harbour-Mount Sinai—FiercePharmaAsia

J&J CAR-T partner Legend aims for U.S. IPO. The FDA's not sure how many drugs and APIs come from China. Harbour teams with Mount Sinai on coronavirus.

Angus Liu Mar 13, 2020 10:26am

Takeda's Ninlaro swings and misses in newly diagnosed myeloma

Mar 10, 2020 12:39pm

AZ-Daiichi, J&J-Legend, Samsung and more—FiercePharmaAsia

Dec 13, 2019 8:48am

Takeda details Ninlaro's miss in AL amyloidosis

Dec 9, 2019 3:41am

Takeda scores a win for Ninlaro in multiple myeloma

Nov 8, 2019 9:54am

Takeda swings and misses with Ninlaro in AL amyloidosis

Jun 6, 2019 12:41pm